Sign in →

Test Code BFLA1 Lipid Analysis, Body Fluid


Necessary Information


1. Date and time of collection are required.

2. Specimen source is required.



Specimen Required


Specimen Type: Body fluid

Preferred Sources:

-Peritoneal fluid (peritoneal, abdominal, ascites, paracentesis)

-Pleural fluid (pleural, chest, thoracentesis)

-Drain fluid (drainage, JP drain)

-Pericardial

Acceptable Source:

Collection Container/Tube: Sterile container, no additive

Submission Container/Tube: Plastic vial

Specimen Volume: 3 mL

Collection Instructions:

1. Centrifuge to remove any cellular material and transfer into a plastic vial.

2. Indicate the specimen source and source location on label.


Secondary ID

614164

Useful For

Distinguishing between chylous and nonchylous effusions

Method Name

Colorimetry/Spectrophotometry (SP)/Electrophoresis

Reporting Name

Lipid Analysis, BF

Specimen Type

Body Fluid

Specimen Minimum Volume

2.5 mL

Specimen Stability Information

Specimen Type Temperature Time Special Container
Body Fluid Frozen (preferred) 30 days
  Refrigerated  7 days
  Ambient  24 hours

Reject Due To

Gross hemolysis OK
Gross lipemia OK
Gross icterus OK
Breast milk
Nasal secretions
Gastric secretions
Bronchoalveolar lavage (BAL or bronchial washings)
Colostomy/ostomy
Amniotic fluid
Feces
Saliva
Sputum
Urine
Spinal fluid
Synovial fluid
Vitreous fluid
Reject

Clinical Information

Measurement of cholesterol and triglycerides combined with detection of chylomicrons in body fluids is useful for diagnosing chylous effusion or differentiating from pseudochylous effusion.(1) Chylous effusions are characterized by the presence of chyle, which contains chylomicrons circulating through the lymphatic system. Pseudochylous effusions do not have chylomicrons. Cholesterol concentrations in serous effusions increase over time due to chronic exudative processes that cause cell lysis or increased vascular permeability. These fluids have a milky appearance can be confused with chylous effusions. While chylous effusions often have elevated triglyceride concentrations and decreased cholesterol concentrations, identification of chylomicrons is considered the gold standard for the diagnosis.

 

Pleural Fluid:

Chylothorax is the name given to pleural effusions containing chylomicrons. They develop when chyle accumulates from disruption of the lymphatic system, often the thoracic duct, caused mainly by malignancy or trauma.(1) Lymph fluid contains chylomicron-rich chyle characterized by high concentrations of triglycerides. Pseudochylous effusions are the name given to milky appearing effusions that do not contain lymphatic contents but rather form gradually through the breakdown of cellular lipids in long-standing effusions such as rheumatoid pleuritis, tuberculosis, or myxedema, and, by definition, the effluent contains high concentrations of cholesterol.(2) Differentiation of pseudochylothorax from chylothorax is important as their milky or opalescent appearance is similar, however therapeutic management strategies differ.

 

Peritoneal Fluid:

Chylous ascites is the name given to peritoneal effusions containing chylomicrons. Obstruction of lymph flow causing leakage from dilated subserosal lymphatics, exudation through the walls of retroperitoneal megalymphatics, and direct leakage of chyle due to a lymphoperitoneal fistula have been proposed as possible mechanisms causing chylous ascites.(3) Elevated triglyceride concentrations have the best correlation with detection of chylomicrons, while cholesterol is not useful at predicting the presence or absence of chylomicrons.

Reference Values

An interpretive report will be provided.

Interpretation

Pleural Fluid:

Pleural fluid cholesterol concentrations 46 to 65 mg/dL are consistent with exudative effusions.

Cholesterol concentrations greater than 200 mg/dL suggest pseudochylous effusion.

Triglyceride concentrations greater than 110 mg/dL are consistent with chylous effusions.

Triglyceride concentrations less than 50 mg/dL are usually not due to chylous effusions.

 

Peritoneal Fluid:

Peritoneal fluid triglyceride concentrations greater than 187 mg/dL are most consistent with chylous effusion.

Cholesterol concentrations 33 to 70 mg/dL suggest malignant causes of ascites.

Method Description

Electrophoresis:

Samples are analyzed for qualitative interpretation of chylomicrons and plasma lipoproteins using a lipid specific Sudan black stain.(Package insert: Hydragel 7, 15 and 30 LIPO + Lp(a). Sebia Inc; 07/2020)

 

Cholesterol:

Cholesterol esters are cleaved by the action of cholesterol esterase to yield free cholesterol and fatty acids. Cholesterol oxidase then catalyzes the oxidation of cholesterol to cholest-4-en-3-one and hydrogen peroxide. In the presence of peroxidase, the hydrogen peroxide formed effects the oxidative coupling of phenol and 4-aminophenazone to form a red quinone-imine dye. The color intensity of the dye formed is directly proportional to the cholesterol concentration. It is determined by measuring the increase in absorbance.(Package insert: Cholesterol Gen2 Reagent. Roche Diagnostics; V 16.0, 10/2023)

 

Triglycerides:

Samples analyzed for triglycerides are measured by an automated enzymatic method. The chemistry includes hydrolysis of the triglycerides and phosphorylation of the resulting glycerol.(Package insert: Triglycerides Reagent. Roche Diagnostics; V13.0, 03/2022)

Day(s) Performed

Monday through Friday

Performing Laboratory

Mayo Clinic Laboratories in Rochester

Test Classification

This test has been modified from the manufacturer's instructions. Its performance characteristics were determined by Mayo Clinic in a manner consistent with CLIA requirements. This test has not been cleared or approved by the US Food and Drug Administration.

CPT Code Information

82664-Electrophoretic technique, not elsewhere specified (Chylomicrons and lipoproteins)

84311-Spectrophotometry, analyte not specified (Cholesterol)

84478-Triglycerides

LOINC Code Information

Test ID Test Order Name Order LOINC Value
BFLA1 Lipid Analysis, BF 94872-9

 

Result ID Test Result Name Result LOINC Value
FLD28 Fluid Type: 14725-6
BFCHO Cholesterol, BF 12183-0
BFTRG Triglycerides, BF 12228-3
BFCMT Comment 21025-2